TransMedics Group (TMDX) Reiterated at Hold by Stifel: Comp Headwinds Ahead
Tweet Send to a Friend
Stifel analyst Thomas Stephan reiterated a Hold rating and $115.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented, "4Q25 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
